Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From ALS
Clinical trial NCT00868166 · COMPLETED
Trial details
- NCT number
- NCT00868166
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-30
- Primary completion
- 2011-09-30
- Enrollment
- 512
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.